Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies

NCT03213314 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT03213314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03213314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HepaT1ca: Quantifying Liver Health in Surgical Candidates for Liver Malignancies
Lead sponsor
University of Edinburgh
Phase
Not applicable
Overall status
Completed
Start date
September 7, 2017
Completion date
March 31, 2019
Enrollment
149 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer metastatic, liver cancer, liver regeneration, surgery